1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
Follow CLL (Chronic Lymphocytic Leukemia): new trials by email Literature Review of CLL (Chronic Lymphocytic Leukemia) trials Research Report on CLL (Chronic Lymphocytic Leukemia)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL MS-553, DS1, MS-553, DS2 - CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma) | Phase 1 / Phase 2 | Not yet recruiting | MingSight Pharmaceuticals, Inc | 12 | 2026-07-01 | 2025-09-29 |
| A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies Lonitoclax (ZE50-0134) - CLL / SLL, CLL (Chronic Lymphocytic Leukemia) | Phase 1 | Recruiting | Lomond Therapeutics Holdings, Inc. | 84 | 2025-04-08 | 2026-07-31 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies Ossium HPC Marrow, Bone Marrow Transplant, Pre-transplant conditioning - Myeloablative (MAC), Pre-transplant conditioning - Reduced Intensity (RIC) - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | Ossium Health, Inc. | 12 | 2024-08-16 | 2026-09-10 |
| Improving Blood Stem Cell Collection and Transplant Procedures Stem Cell Transplantation - Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 43 | 2012-01-13 | 2018-07-05 |
Leukemia, B-Cell (4) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Hematologic Diseases (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, T-Cell, Cutaneous (1) · Myelodysplastic Syndromes (1) · Recurrence (1)
Chronic Disease (4) · Disease Attributes (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Hematologic Diseases (3) · Bone Marrow Diseases (2) · Leukemia (2)
Bone Marrow Transplantation (1) · Cyclophosphamide (1) · Filgrastim (1) · Melphalan (1) · Mesna (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · fludarabine phosphate (1)
Lomond Therapeutics Holdings, Inc. (1) · MingSight Pharmaceuticals, Inc (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Ossium Health, Inc. (1)
United States (3)